Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Port & Shipping Industry Fund is a Chinese private equity and venture capital firm that manages industrial investment funds. While its primary focus includes port logistics and shipping infrastructure, the firm has become a significant financial player in the Chinese life sciences sector through strategic investments. The fund has participated in the financing of major biotech and CRO entities, including BrightGene Bio-Medical Technology and Joinn Laboratories. It operates by identifying high-growth opportunities in the Liaoning region and across China, supporting the commercialization of innovative medical technologies. The firm provides capital and strategic support to help portfolio companies navigate capital markets and scale their operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Port & Shipping Industry Fund.